| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30ac51950f223976c5310e500b73d580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78587acbfc8d4c9e9ac3baa7021087d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd01d6597162172912543de849fc0156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44a493cbe075f78e03b743ea71bc978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7f9397fa3a42ef1011cb5baf41d9f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb9083e6b86b9a022c58ee4d17723fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f645d2a153041b8ac23c2caa5bc38984 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021113551-A1 |
| titleOfInvention |
Therapeutic compounds for methods of use in insulin resistance |
| abstract |
Embodiments of the disclosure encompass methods of treating insulin resistance in an individual in need thereof by administering one or more STAT3 inhibitors to the individual. In specific aspects, the methods allow for reversing insulin resistance in individuals. The STAT3 inhibitor may be one or more particular small molecules encompassed herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023126951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023045910-A1 |
| priorityDate |
2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |